CAR T-cells for colorectal cancer immunotherapy: Ready to go?

CAR T-cells for colorectal cancer immunotherapy: Ready to go?

Chimeric antigen receptor (CAR) T-cells represent a new genetically engineered cell-based immunotherapy tool against cancer. The use of CAR T-cells has revolutionized the therapeutic approach for hematological malignancies. Unfortunately, there is a long way to go before this treatment can be develo...

Full description

Bibliographic Details
Main Authors: Bouchra Ghazi, Adil El Ghanmi, Sarah Kandoussi, Amina Ghouzlani, Abdallah Badou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Immunology
Subjects:
colorectal cancer
CAR T cells
immunotherapies
tumor microenvironement
tumor mutational burden
clinical data
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.978195/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.978195/full

Similar Items